Veracyte Non Current Liabilities Total vs Common Stock Analysis

VCYT Stock

USD 42.95 0.06 0.14%

Veracyte financial indicator trend analysis is much more than just breaking down Veracyte prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Veracyte is a good investment. Please check the relationship between Veracyte Non Current Liabilities Total and its Common Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Non Current Liabilities Total vs Common Stock

Non Current Liabilities Total vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Veracyte Non Current Liabilities Total account and Common Stock. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Veracyte's Non Current Liabilities Total and Common Stock is 0.59. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock in the same time period over historical financial statements of Veracyte, assuming nothing else is changed. The correlation between historical values of Veracyte's Non Current Liabilities Total and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Veracyte are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Non Current Liabilities Total i.e., Veracyte's Non Current Liabilities Total and Common Stock go up and down completely randomly.

Correlation Coefficient

0.59

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Non Current Liabilities Total

Common Stock

Most indicators from Veracyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Veracyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.At this time, Veracyte's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 392.7 K in 2024, whereas Enterprise Value Multiple is likely to drop (38.14) in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	227.0M	236.0M	333.9M	350.6M
Cost Of Revenue	74.4M	101.6M	112.9M	118.5M

Total Operating Expenses Cost Of Revenue

Veracyte fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment
Total Assets		0.98	0.98	1.0	0.76	0.96	-0.68	-0.88	0.9	0.61	0.98	-0.49	0.31	0.63	0.97	0.9	0.85	0.28	0.95	0.97	0.99	0.84	0.88	0.73	0.81	0.96
Other Current Liab	0.98		1.0	0.97	0.74	0.95	-0.57	-0.85	0.95	0.5	0.98	-0.51	0.2	0.53	0.96	0.89	0.81	0.31	0.96	0.97	0.96	0.87	0.87	0.64	0.8	0.97
Total Current Liabilities	0.98	1.0		0.98	0.73	0.94	-0.57	-0.85	0.96	0.5	0.99	-0.49	0.18	0.53	0.95	0.88	0.8	0.28	0.96	0.97	0.97	0.85	0.88	0.64	0.78	0.97
Total Stockholder Equity	1.0	0.97	0.98		0.75	0.96	-0.68	-0.87	0.9	0.61	0.98	-0.48	0.3	0.63	0.97	0.89	0.84	0.26	0.94	0.97	0.99	0.83	0.88	0.73	0.8	0.96
Other Liab	0.76	0.74	0.73	0.75		0.81	-0.7	-0.73	0.61	0.74	0.7	-0.55	0.5	0.74	0.78	0.77	0.84	0.53	0.66	0.78	0.76	0.86	0.56	0.81	0.84	0.71
Property Plant And Equipment Net	0.96	0.95	0.94	0.96	0.81		-0.71	-0.94	0.85	0.66	0.93	-0.42	0.34	0.68	0.98	0.96	0.9	0.44	0.96	0.93	0.98	0.87	0.88	0.77	0.88	0.96
Net Debt	-0.68	-0.57	-0.57	-0.68	-0.7	-0.71		0.69	-0.48	-0.97	-0.53	0.1	-0.7	-0.97	-0.67	-0.77	-0.71	-0.25	-0.61	-0.56	-0.69	-0.52	-0.57	-0.94	-0.74	-0.56
Retained Earnings	-0.88	-0.85	-0.85	-0.87	-0.73	-0.94	0.69		-0.75	-0.65	-0.83	0.25	-0.34	-0.67	-0.94	-0.95	-0.92	-0.5	-0.91	-0.83	-0.94	-0.82	-0.86	-0.75	-0.87	-0.91
Accounts Payable	0.9	0.95	0.96	0.9	0.61	0.85	-0.48	-0.75		0.4	0.92	-0.41	0.07	0.42	0.85	0.82	0.68	0.19	0.92	0.91	0.89	0.78	0.85	0.52	0.7	0.91
Cash	0.61	0.5	0.5	0.61	0.74	0.66	-0.97	-0.65	0.4		0.46	-0.17	0.77	1.0	0.63	0.73	0.75	0.33	0.53	0.5	0.63	0.57	0.45	0.98	0.79	0.49
Non Current Assets Total	0.98	0.98	0.99	0.98	0.7	0.93	-0.53	-0.83	0.92	0.46		-0.54	0.18	0.49	0.95	0.83	0.79	0.23	0.93	0.98	0.96	0.83	0.86	0.61	0.74	0.96
Non Currrent Assets Other	-0.49	-0.51	-0.49	-0.48	-0.55	-0.42	0.1	0.25	-0.41	-0.17	-0.54		-0.38	-0.2	-0.46	-0.27	-0.48	-0.29	-0.28	-0.56	-0.42	-0.64	-0.06	-0.3	-0.44	-0.37
Other Assets	0.31	0.2	0.18	0.3	0.5	0.34	-0.7	-0.34	0.07	0.77	0.18	-0.38		0.79	0.34	0.38	0.53	0.33	0.16	0.18	0.32	0.36	-0.03	0.75	0.54	0.14
Cash And Short Term Investments	0.63	0.53	0.53	0.63	0.74	0.68	-0.97	-0.67	0.42	1.0	0.49	-0.2	0.79		0.65	0.74	0.77	0.33	0.55	0.52	0.65	0.59	0.46	0.99	0.81	0.51
Net Receivables	0.97	0.96	0.95	0.97	0.78	0.98	-0.67	-0.94	0.85	0.63	0.95	-0.46	0.34	0.65		0.95	0.9	0.44	0.96	0.94	0.99	0.89	0.87	0.75	0.87	0.96
Common Stock Total Equity	0.9	0.89	0.88	0.89	0.77	0.96	-0.77	-0.95	0.82	0.73	0.83	-0.27	0.38	0.74	0.95		0.88	0.52	0.93	0.85	0.94	0.85	0.86	0.81	0.92	0.91
Common Stock Shares Outstanding	0.85	0.81	0.8	0.84	0.84	0.9	-0.71	-0.92	0.68	0.75	0.79	-0.48	0.53	0.77	0.9	0.88		0.49	0.81	0.8	0.89	0.9	0.69	0.86	0.95	0.81
Non Current Liabilities Total	0.28	0.31	0.28	0.26	0.53	0.44	-0.25	-0.5	0.19	0.33	0.23	-0.29	0.33	0.33	0.44	0.52	0.49		0.32	0.33	0.35	0.62	0.2	0.37	0.59	0.36
Inventory	0.95	0.96	0.96	0.94	0.66	0.96	-0.61	-0.91	0.92	0.53	0.93	-0.28	0.16	0.55	0.96	0.93	0.81	0.32		0.9	0.96	0.8	0.95	0.65	0.8	0.97
Other Current Assets	0.97	0.97	0.97	0.97	0.78	0.93	-0.56	-0.83	0.91	0.5	0.98	-0.56	0.18	0.52	0.94	0.85	0.8	0.33	0.9		0.95	0.86	0.85	0.63	0.76	0.95
Other Stockholder Equity	0.99	0.96	0.97	0.99	0.76	0.98	-0.69	-0.94	0.89	0.63	0.96	-0.42	0.32	0.65	0.99	0.94	0.89	0.35	0.96	0.95		0.85	0.9	0.75	0.84	0.97
Total Liab	0.84	0.87	0.85	0.83	0.86	0.87	-0.52	-0.82	0.78	0.57	0.83	-0.64	0.36	0.59	0.89	0.85	0.9	0.62	0.8	0.86	0.85		0.65	0.71	0.92	0.84
Property Plant And Equipment Gross	0.88	0.87	0.88	0.88	0.56	0.88	-0.57	-0.86	0.85	0.45	0.86	-0.06	-0.03	0.46	0.87	0.86	0.69	0.2	0.95	0.85	0.9	0.65		0.54	0.65	0.94
Total Current Assets	0.73	0.64	0.64	0.73	0.81	0.77	-0.94	-0.75	0.52	0.98	0.61	-0.3	0.75	0.99	0.75	0.81	0.86	0.37	0.65	0.63	0.75	0.71	0.54		0.88	0.62
Common Stock	0.81	0.8	0.78	0.8	0.84	0.88	-0.74	-0.87	0.7	0.79	0.74	-0.44	0.54	0.81	0.87	0.92	0.95	0.59	0.8	0.76	0.84	0.92	0.65	0.88		0.78
Property Plant Equipment	0.96	0.97	0.97	0.96	0.71	0.96	-0.56	-0.91	0.91	0.49	0.96	-0.37	0.14	0.51	0.96	0.91	0.81	0.36	0.97	0.95	0.97	0.84	0.94	0.62	0.78

Click cells to compare fundamentals

Veracyte Account Relationship Matchups

Veracyte fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	275.2M	457.2M	1.2B	1.2B	1.1B	1.2B
Other Current Liab	13.7M	10.1M	38.8M	40.0M	36.1M	37.9M
Total Current Liabilities	17.5M	16.8M	64.2M	62.6M	61.2M	64.3M
Total Stockholder Equity	239.5M	421.2M	1.1B	1.1B	1.0B	1.1B
Other Liab	6.1M	8.4M	13.1M	7.6M	8.7M	5.6M
Property Plant And Equipment Net	17.7M	16.8M	31.1M	30.9M	30.9M	32.4M
Net Debt	(145.7M)	(337.0M)	(154.3M)	(139.5M)	(203.8M)	(193.6M)
Retained Earnings	(246.7M)	(281.6M)	(357.2M)	(393.7M)	(468.1M)	(444.7M)
Accounts Payable	2.3M	3.1M	12.4M	11.9M	12.9M	13.6M
Cash	159.3M	349.4M	173.2M	154.2M	216.5M	117.7M
Non Current Assets Total	87.5M	81.5M	944.7M	907.8M	829.3M	870.7M
Non Currrent Assets Other	2.0M	2.0M	(35.1M)	(26.8M)	6.8M	7.2M
Other Assets	2.0M	9.8M	2.9M	6.2M	1.0	0.95
Cash And Short Term Investments	159.3M	349.4M	173.2M	178.9M	216.5M	119.7M
Net Receivables	19.3M	18.5M	41.5M	44.0M	40.4M	42.4M
Common Stock Total Equity	50K	58K	71K	72K	82.8K	86.9K
Common Stock Shares Outstanding	46.1M	53.2M	67.9M	71.5M	72.6M	41.6M
Liabilities And Stockholders Equity	275.2M	457.2M	1.2B	1.2B	1.1B	1.2B
Non Current Liabilities Total	18.3M	19.2M	27.2M	18.6M	9.6M	17.6M
Inventory	6.8M	4.7M	11.2M	14.3M	16.1M	16.9M
Other Current Assets	2.2M	3.2M	17.2M	11.5M	12.7M	13.3M
Other Stockholder Equity	486.1M	702.8M	1.5B	1.5B	1.5B	1.6B
Total Liab	35.8M	35.9M	91.3M	81.2M	70.8M	44.5M
Property Plant And Equipment Gross	17.7M	9.0M	31.1M	30.9M	63.7M	66.9M
Total Current Assets	187.7M	375.7M	243.1M	248.6M	285.6M	148.7M
Accumulated Other Comprehensive Income	(12.0M)	0.0	(15.1M)	(31.3M)	(24.0M)	(22.8M)
Common Stock	50K	58K	71K	72K	73K	42.9K
Property Plant Equipment	8.9M	9.0M	31.1M	30.9M	35.5M	37.3M
Short Long Term Debt Total	13.6M	12.3M	18.9M	14.7M	12.6M	16.8M
Net Tangible Assets	171.7M	358.6M	185.9M	379.3M	436.2M	458.0M
Long Term Debt	25.2M	23.9M	694K	810K	931.5K	884.9K
Retained Earnings Total Equity	(246.7M)	(281.6M)	(357.2M)	(393.7M)	(354.3M)	(372.1M)
Long Term Debt Total	25.2M	23.9M	694K	810K	931.5K	884.9K
Capital Surpluse	486.1M	702.8M	1.5B	1.5B	1.7B	1.8B
Deferred Long Term Liab	4.2M	3.9M	5.6M	4.5M	5.2M	4.3M
Intangible Assets	65.0M	59.9M	202.7M	174.9M	88.6M	66.2M
Short Term Debt	1.4M	3.2M	8.4M	8.1M	10.2M	7.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC